Call us at (952) 920-7001

BOTOX® Cosmetic

You’ve probably heard of BOTOX® Cosmetic, but did you know: it’s the first and only FDA-approved treatment to temporarily smooth moderate to severe forehead lines, crow’s feet lines, and frown lines in adults. BOTOX® Cosmetic is a one-of-a-kind formulation—there’s nothing exactly like it. So, if you’re bothered by those deepening lines and have thought about treatment to temporarily reduce them, ask for BOTOX® Cosmetic.

 

dr jaqua administering botox to a female patient

Call 952-920-7001 to schedule an appointment.
(This procedure is available ONLY at the Edina location.)

 

  • What can it treat?

    forehead lines on womanFor temporary improvement of moderate to severe forehead lines, BOTOX® Cosmetic is injected into the frontalis muscle above your eyebrows.

    crow's feet lines on womanFor temporary improvement of moderate to severe crow’s feet lines, BOTOX® Cosmetic is injected into the orbicularis oculi muscle surrounding your eyes.

    frown lines on womanFor temporary improvement of moderate to severe frown lines, BOTOX® Cosmetic is injected into the corrugator and procerus muscles in your brow area.

  • What happens during the treatment?

    Minimal downtime: A quick treatment that’s easy to fit into your busy schedule—get in, out, and on with your day.

    Feels like a pinch: Your physician uses a very small surgical needle the BOTOX® Cosmetic solution is injected into the troublespots.

    Real noticeable results: You may begin to see results within 24 to 48 hours after treatment with BOTOX® Cosmetic. The weakening effect gradually begins over 2-7 days and is not complete for two weeks. Therefore, optimal results are not seen for at least two weeks and sometimes longer.

  • After Treatment

    Follow these easy tips at home after your treatment with Botox® Cosmetic.

    • You should be able to go about your normal routine right after you leave your specialist’s office. Minimal downtime or recovery period is necessary.
    • Remember that you probably won’t notice results until 24 to 48 hours have elapsed. In clinical trials, a majority of people saw significant improvement at 7 days, continuing for up to a month.
    • Side effects associated with the injection include localized pain, infection, inflammation, tenderness, swelling, redness, and/or bleeding/bruising. Call your specialist if you have questions or concerns.
    • Results for frown line treatments last up to 4 months with a physician-reported response of 25% (102/403) vs 2% (2/128) for placebo. So ask your doctor if it’s a good time to schedule your next treatment.
    • What to avoid: BOTOX® Cosmetic may cause loss of strength or general muscle weakness, or vision problems within hours to weeks of receiving BOTOX® Cosmetic. If any of this happens, do not drive a car, operate machinery, or do other dangerous activities.

    *Contact your doctor for the full details following your procedure(s) or with further questions.

  • Frequently Asked Questions

    Will I look overdone?

    You should not lose the ability to show expression when you are treated by someone who is licensed, trained, and a medical expert in facial anatomy. It is important to talk to your aesthetic specialist about the results you want from treatment.

    What were common side effects seen in clinical studies?

    In studies for forehead lines, 9% of patients experienced headache, 2% had brow drooping, and 2% had eyelid drooping. In the frown line studies, 3% of patients experienced eyelid drooping, and in the crow’s feet studies, 1% of patients experienced eyelid swelling. Other possible side effects include: discomfort or pain at the injection site; headache; and eye problems: double vision, blurred vision, drooping eyelids, dry eyes, and swelling of your eyelids.

    These are not all of the possible serious side

    effects of BOTOX® Cosmetic. Please talk to

    your specialist

Disclaimer

  • BOTOX® Cosmetic (onabotulinumtoxinA) Important Information (click to view full disclaimer)

    INDICATIONS

    BOTOX® Cosmetic (onabotulinumtoxinA) is indicated in adult patients for the temporary improvement in the appearance of:

    • moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity
    • moderate to severe lateral canthal lines associated with orbicularis oculi activity
    • moderate to severe forehead lines associated with frontalis activity

    IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING

    WARNING: DISTANT SPREAD OF TOXIN EFFECT
    Postmarketing reports indicate that the effects of BOTOX® Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have an underlying condition that would predispose them to these symptoms. In unapproved uses, including spasticity in children, and in approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and spasticity and at lower doses.

    CONTRAINDICATIONS

    BOTOX® Cosmetic is contraindicated in the presence of infection at the proposed injection site(s) and in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation.

    WARNINGS AND PRECAUTIONS

    Lack of Interchangeability between Botulinum Toxin Products

    The potency Units of BOTOX® Cosmetic are specific to the preparation and assay method utilized. They are not interchangeable with other preparations of botulinum toxin products and, therefore, units of biological activity of BOTOX® Cosmetic cannot be compared to nor converted into units of any other botulinum toxin products assessed with any other specific assay method.

    Spread of Toxin Effect

    Please refer to Boxed Warning for Distant Spread of Toxin Effect.
    No definitive serious adverse event reports of distant spread of toxin effect associated with dermatologic use of BOTOX® Cosmetic at the labeled dose of 20 Units (for glabellar lines), 24 Units (for lateral canthal lines), 40 Units (for forehead lines with glabellar lines), 44 Units (for simultaneous treatment of lateral canthal lines and glabellar lines), and 64 Units (for simultaneous treatment of lateral canthal lines, glabellar lines, and forehead lines) have been reported.

    Serious Adverse Reactions With Unapproved Use

    Serious adverse reactions, including excessive weakness, dysphagia, and aspiration pneumonia, with some adverse reactions associated with fatal outcomes, have been reported in patients who received BOTOX® injections for unapproved uses. In these cases, the adverse reactions were not necessarily related to distant spread of toxin, but may have resulted from the administration of BOTOX® to the site of injection and/or adjacent structures. In several of the cases, patients had pre-existing dysphagia or other significant disabilities. There is insufficient information to identify factors associated with an increased risk for adverse reactions associated with the unapproved uses of BOTOX®. The safety and effectiveness of BOTOX® for unapproved uses have not been established.

    Hypersensitivity Reactions

    Serious and/or immediate hypersensitivity reactions have been reported. These reactions include anaphylaxis, serum sickness, urticaria, soft-tissue edema, and dyspnea. If such reactions occur, further injection of BOTOX® Cosmetic should be discontinued and appropriate medical therapy immediately instituted. One fatal case of anaphylaxis has been reported in which lidocaine was used as the diluent and, consequently, the causal agent cannot be reliably determined.

    Cardiovascular System

    There have been reports following administration of BOTOX® of adverse events involving the cardiovascular system, including arrhythmia and myocardial infarction, some with fatal outcomes. Some of these patients had risk factors including pre-existing cardiovascular disease. Use caution when administering to patients with pre-existing cardiovascular disease.

    Increased Risk of Clinically Significant Effects with Pre-existing Neuromuscular Disorders

    Individuals with peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, or neuromuscular junction disorders (eg, myasthenia gravis or Lambert-Eaton syndrome) should be monitored when given botulinum toxin. Patients with neuromuscular disorders may be at increased risk of clinically significant effects including generalized muscle weakness, diplopia, ptosis, dysphonia, dysarthria, severe dysphagia, and respiratory compromise from onabotulinumtoxinA (see Warnings and Precautions).

    Dysphagia and Breathing Difficulties

    Treatment with BOTOX® and other botulinum toxin products can result in swallowing or breathing difficulties. Patients with pre-existing swallowing or breathing difficulties may be more susceptible to these complications. In most cases, this is a consequence of weakening of muscles in the area of injection that are involved in breathing or oropharyngeal muscles that control swallowing or breathing (see Boxed Warning).

    Pre-existing Conditions at the Injection Site

    Caution should be used when BOTOX® Cosmetic treatment is used in the presence of inflammation at the proposed injection site(s) or when excessive weakness or atrophy is present in the target muscle(s).

    Human Albumin and Transmission of Viral Diseases

    This product contains albumin, a derivative of human blood. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases and variant Creutzfeldt-Jakob disease (vCJD). There is a theoretical risk for transmission of Creutzfeldt-Jakob disease (CJD), but if that risk actually exists, the risk of transmission would also be considered extremely remote. No cases of transmission of viral diseases, CJD or vCJD have ever been identified for licensed albumin or albumin contained in other licensed products.

    ADVERSE REACTIONS

    The most frequently reported adverse reaction following injection of BOTOX® Cosmetic for glabellar lines was eyelid ptosis (3%).

    The most frequently reported adverse reaction following injection of BOTOX® Cosmetic for lateral canthal lines was eyelid edema (1%).

    The most frequently reported adverse reactions following injection of BOTOX® Cosmetic for forehead lines with glabellar lines were headache (9%), brow ptosis (2%) and eyelid ptosis (2%).

    DRUG INTERACTIONS

    Co-administration of BOTOX® Cosmetic and aminoglycosides or other agents interfering with neuromuscular transmission (eg, curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated. Use of anticholinergic drugs after administration of BOTOX® Cosmetic may potentiate systemic anticholinergic effects.

    The effect of administering different botulinum neurotoxin products at the same time or within several months of each other is unknown. Excessive neuromuscular weakness may be exacerbated by administration of another botulinum toxin prior to the resolution of the effects of a previously administered botulinum toxin.

    Excessive weakness may also be exaggerated by administration of a muscle relaxant before or after administration of BOTOX® Cosmetic.

    USE IN SPECIFIC POPULATIONS

    There are no studies or adequate data from postmarketing surveillance on the developmental risk associated with use of BOTOX® Cosmetic in pregnant women. There are no data on the presence of BOTOX® Cosmetic in human or animal milk, the effects on the breastfed child, or the effects on milk production.

    Please see BOTOX® Cosmetic full Prescribing Information including Boxed Warning and Medication Guide.

Contact Us

Contact Us

  • Monday - Friday
    8:00 am - 4:30 pm
  • Providers Available After Hours for Emergencies
  • Click here to fill out our contact form

Patient Portal

For your convenience you may call our office, use our patient portal or use our online appointment form.

Contact Our Triage Nurses

Edina Location

Southdale ObGyn Consultants

3625 West 65th, Suite 100
Edina, MN 55435
Get directions: To here - From here

Phone: 952-920-7001
Fax: 952-920-2245

Schedule an Appointment

Burnsville Location

Southdale ObGyn Consultants

305 East Nicollet Blvd. Suite 393
Burnsville, MN 55337
Get directions: To here - From here

Phone: 952-435-9505
Fax: 952-435-6205

Schedule an Appointment